Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
monday.com
MNDY
$3.55B
| $343M | 0.46% |
1,090,790
-91,600
| -8% | -$25.5M |
2021 Q4
14 quarters
|
|
27
Hims & Hers Health
HIMS
$6.51B
| $342M | 0.46% |
6,869,452
-154,900
| -2% | -$7M |
2021 Q2
16 quarters
|
|
28
Duolingo
DUOL
$7.07B
| $342M | 0.45% |
833,800
+318,100
| +62% | +$140M |
2022 Q3
11 quarters
|
|
29
Carvana
CVNA
$45.3B
| $341M | 0.45% |
5,065,560
+3,872,000
| +324% | +$212M |
2023 Q3
7 quarters
|
|
|
NVO
30
Novo Nordisk
NVO
$166B
| $341M | 0.45% |
4,936,796
-1,884,600
| -28% | -$128M |
2013 Q2
48 quarters
|
|
31
Coinbase
COIN
$45.9B
| $307M | 0.41% |
877,300
-101,000
| -10% | -$23.6M |
2025 Q1
1 quarter
|
|
32
Airbnb
ABNB
$95.8B
| $304M | 0.4% |
2,297,042
-1,530,882
| -40% | -$194M |
2021 Q2
16 quarters
|
|
33
Atlassian
TEAM
$50.3B
| $301M | 0.4% |
1,480,823
-13,400
| -0.9% | -$2.79M |
2016 Q2
36 quarters
|
|
34
Neurocrine Biosciences
NBIX
$14.3B
| $297M | 0.4% |
2,366,397
-136,300
| -5% | -$15.6M |
2018 Q4
26 quarters
|
|
35
Dropbox
DBX
$7.26B
| $289M | 0.38% |
10,099,898
-415,100
| -4% | -$11.8M |
2019 Q1
25 quarters
|
|
36
CME Group
CME
$99.7B
| $287M | 0.38% |
1,042,489
+226,800
| +28% | +$61.7M |
2021 Q3
15 quarters
|
|
37
Commault Systems
CVLT
$6.28B
| $283M | 0.38% |
1,621,685
-70,400
| -4% | -$12M |
2013 Q2
48 quarters
|
|
38
Allison Transmission
ALSN
$8.82B
| $281M | 0.37% |
2,958,524
-156,700
| -5% | -$15.1M |
2013 Q3
47 quarters
|
|
39
Zoom
ZM
$27.4B
| $281M | 0.37% |
3,600,148
-31,700
| -0.9% | -$2.45M |
2020 Q1
21 quarters
|
|
40
Novartis
NVS
$268B
| $278M | 0.37% |
2,298,151
+10,900
| +0.5% | +$1.23M |
2013 Q3
47 quarters
|
|
|
DOCU
41
DocuSign
DOCU
$12.9B
| $269M | 0.36% |
3,449,788
-393,100
| -10% | -$31.8M |
2019 Q3
23 quarters
|
|
42
Incyte
INCY
$22.3B
| $264M | 0.35% |
3,881,932
+173,200
| +5% | +$11M |
2017 Q4
30 quarters
|
|
43
Tradeweb Markets
TW
$23.1B
| $256M | 0.34% |
1,748,220
-59,600
| -3% | -$8.32M |
2021 Q3
15 quarters
|
|
44
Colgate-Palmolive
CL
$69.9B
| $252M | 0.34% |
2,770,410
-144,000
| -5% | -$13.1M |
2013 Q2
48 quarters
|
|
45
AT&T
T
$169B
| $251M | 0.33% |
8,669,317
+6,107,431
| +238% | +$168M |
2025 Q1
1 quarter
|
|
46
Sterling Infrastructure
STRL
$16.1B
| $250M | 0.33% |
1,083,371
+53,917
| +5% | +$9.41M |
2013 Q2
48 quarters
|
|
47
Reddit
RDDT
$30B
| $242M | 0.32% |
1,607,600
-320,600
| -17% | -$36.3M |
2024 Q2
4 quarters
|
|
48
GE Aerospace
GE
$313B
| $235M | 0.31% |
914,159
+287,358
| +46% | +$63.1M |
2024 Q3
3 quarters
|
|
49
Brinker International
EAT
$7.89B
| $235M | 0.31% |
1,302,665
+300,100
| +30% | +$47.1M |
2023 Q4
6 quarters
|
|
50
National Grid
NGG
$76.7B
| $234M | 0.31% |
3,191,454
+54,782
| +2% | +$3.76M |
2013 Q2
48 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.